Vascular smooth muscle cell proliferation as a therapeutic target. Part 2: Natural products inhibiting proliferation

• Published in: Biotechnology advances Vol. 36; no. 6; pp. 1608 - 1621
• Main Authors: Uhrin, Pavel, Wang, Dongdong, Mocan, Andrei, Waltenberger, Birgit, Breuss, Johannes M., Tewari, Devesh, Mihaly-Bison, Judit, Huminiecki, Łukasz, Starzyński, Rafał R., Tzvetkov, Nikolay T., Horbańczuk, Jarosław, Atanasov, Atanas G.
• Format: Journal Article
• Language: English
• Published: England Elsevier Inc 01.11.2018; Elsevier Science Ltd
• Subjects: Atherosclerosis; Cancer; Cell growth; cell proliferation; Drug-discovery; Hypertension; Inhibitors; Molecular target; Muscles; Natural products; paclitaxel; pelargonidin; Rapamycin; Restenosis; resveratrol; Signaling pathway; smooth muscle; Taxol; therapeutics; Vascular endothelial growth factor; Vascular smooth muscle cell proliferation; Restenosis; Molecular target; Signaling pathway; Drug-discovery; Natural products; Atherosclerosis; Vascular smooth muscle cell proliferation
• ISSN: 0734-9750; 1873-1899; 1873-1899
• DOI: 10.1016/j.biotechadv.2018.04.002

Many natural products have been so far tested regarding their potency to inhibit vascular smooth muscle cell proliferation, a process involved in atherosclerosis, pulmonary hypertension and restenosis. Compounds studied in vitro and in vivo as VSMC proliferation inhibitors include, for example indirubin-3′-monoxime, resveratrol, hyperoside, plumericin, pelargonidin, zerumbone and apamin. Moreover, taxol and rapamycin, the most prominent compounds applied in drug-eluting stents to counteract restenosis, are natural products. Numerous studies show that natural products have proven to yield effective inhibitors of vascular smooth muscle cell proliferation and ongoing research effort might result in the discovery of further clinically relevant compounds.